Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With CancerKevin C. Conlon, Thomas A. Waldmann, Steven A. Rosenberg et al.|Journal of Clinical Oncology|2014Cited by 714
BCL-6 suppresses miR-142-3p/5p expression in SLE CD4+ T cells by modulating histone methylation and acetylation of the miR-142 promoterShu Ding, Qianjin Lu, Qing Zhang et al.|Cellular and Molecular Immunology|2019Cited by 45